Loading...

Immunotherapy updates in pancreatic cancer: are we there yet?

Pancreatic cancer is a lethal disease and remains one of the most resistant cancers to traditional therapies. Historically, chemotherapy or radiotherapy did not provide meaningful survival benefit in advanced pancreatic cancer. Gemcitabine and recently FOLFIRINOX (5-flourouracil, leucovorin, oxalipl...

Full description

Saved in:
Bibliographic Details
Main Authors: Gunturu, Krishna Soujanya, Rossi, Gabriela R., Saif, Muhammad Wasif
Format: Artigo
Language:Inglês
Published: SAGE Publications 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539275/
https://ncbi.nlm.nih.gov/pubmed/23323149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012462463
Tags: Add Tag
No Tags, Be the first to tag this record!